Precision BioSciences Profit Margin vs. Price To Book
| DTIL Stock | USD 6.18 0.03 0.48% |
Precision BioSciences Net Profit Margin |
|
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.59 | 0.8306 |
|
|
For Precision BioSciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Precision BioSciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Precision BioSciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Precision BioSciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Precision BioSciences over time as well as its relative position and ranking within its peers.
Precision |
Precision BioSciences' Revenue Breakdown by Earning Segment
Check out Investing Opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.4 | Revenue Per Share 12.872 | Quarterly Revenue Growth (0.96) | Return On Assets (0.06) | Return On Equity 0.2444 |
The market value of Precision BioSciences is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Precision BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision BioSciences' market value can be influenced by many factors that don't directly affect Precision BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precision BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Precision BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Precision BioSciences Price To Book vs. Profit Margin Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Precision BioSciences's current stock value. Our valuation model uses many indicators to compare Precision BioSciences value to that of its competitors to determine the firm's financial worth. Precision BioSciences is rated # 2 in profit margin category among its peers. It is rated below average in price to book category among its peers fabricating about 7.08 of Price To Book per Profit Margin. At this time, Precision BioSciences' Net Loss is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Precision BioSciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Precision Price To Book vs. Profit Margin
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Precision BioSciences |
| = | 0.11 % |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Precision BioSciences |
| = | 0.81 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Precision Price To Book Comparison
Precision BioSciences is currently under evaluation in price to book category among its peers.
Precision BioSciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Precision BioSciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Precision BioSciences will eventually generate negative long term returns. The profitability progress is the general direction of Precision BioSciences' change in net profit over the period of time. It can combine multiple indicators of Precision BioSciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -9.6 M | -10.1 M | |
| Interest Income | 7.8 M | 8.2 M | |
| Operating Income | -43.7 M | -45.9 M | |
| Net Loss | -87.2 M | -91.6 M | |
| Income Before Tax | -42.5 M | -44.7 M | |
| Total Other Income Expense Net | 1.2 M | 1.1 M | |
| Net Loss | -100.5 M | -95.4 M | |
| Net Loss | -61.3 M | -64.4 M | |
| Income Tax Expense | 27.2 M | 28.6 M | |
| Net Interest Income | 5.7 M | 5.9 M | |
| Non Operating Income Net Other | -10.1 M | -9.6 M | |
| Change To Netincome | 37.8 M | 39.6 M | |
| Net Loss | (15.96) | (16.76) | |
| Income Quality | 1.37 | 1.44 | |
| Net Income Per E B T | 1.44 | 0.87 |
Precision Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Precision BioSciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Precision BioSciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Precision BioSciences' important profitability drivers and their relationship over time.
Use Precision BioSciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Precision BioSciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Precision BioSciences will appreciate offsetting losses from the drop in the long position's value.Precision BioSciences Pair Trading
Precision BioSciences Pair Trading Analysis
The ability to find closely correlated positions to Precision BioSciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Precision BioSciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Precision BioSciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Precision BioSciences to buy it.
The correlation of Precision BioSciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Precision BioSciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Precision BioSciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Precision BioSciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Precision BioSciences position
In addition to having Precision BioSciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Beers Thematic Idea Now
Beers
Companies involved in production and distribution of domestic and international beer. The Beers theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Beers Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Investing Opportunities. For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
To fully project Precision BioSciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Precision BioSciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Precision BioSciences' income statement, its balance sheet, and the statement of cash flows.